AbbVie to acquire Allergan in USD63bn deal

25 June 2019 - Deborah Wilkes

Premium

Biopharmaceutical company AbbVie is set to acquire Botox-maker Allergan in a cash and shares deal worth approximately USD63 billion.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: